Dewey McLin
Hoofd Techniek/Wetenschap/O&O bij LONGBOARD PHARMACEUTICALS, INC.
Profiel
Dewey McLin is currently the Vice President & Head-Medical Affairs at Longboard Pharmaceuticals, Inc. Previously, he held the position of Senior Director-Medical Affairs at Greenwich Biosciences, Inc. In 2021, he briefly served as the Vice President-Medical Affairs at Sesen Bio, Inc. Dr. McLin completed his undergraduate degree at Indiana University and obtained a doctorate from the University of California, Irvine.
Actieve functies van Dewey McLin
| Bedrijven | Functie | Begin |
|---|---|---|
| LONGBOARD PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Eerdere bekende functies van Dewey McLin
| Bedrijven | Functie | Einde |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-09-2021 |
Greenwich Biosciences, Inc.
 Greenwich Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Greenwich Biosciences, Inc. develops and markets cannabinoid prescription medicines through online. The company is headquartered in Carlsbad, CA. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Dewey McLin
| Indiana University | Undergraduate Degree |
| University of California, Irvine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| LONGBOARD PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
Greenwich Biosciences, Inc.
Greenwich Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Greenwich Biosciences, Inc. develops and markets cannabinoid prescription medicines through online. The company is headquartered in Carlsbad, CA. | Health Technology |
